RxDoctor Payments Data

Keith Regets, PA

Physician Assistant · Arlington, TXNPI 1164725677

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $87,033 of the $119,424 with a category attached, or 72.9%. Antares Pharma, Inc. accounts for 64.4% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2022 at $36,607 and has fallen 62.3% since, to $13,818 in 2025. Among physician assistant clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$119,424in general payments, 2019–2025

Across 314 payments — averaging $380.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Antares Pharma, Inc.$77K
  • Boston Scientific$28K
  • Endo USA, Inc.$5K
  • Endo Pharmaceuticals Inc.$4K
  • Verity Pharmaceuticals Inc.$4K
  • Halozyme Inc$706
  • plus $1K from 14 others

What the payments were for

  • Consulting fees$12,02010%
  • Speaking & faculty fees$87,03373%
  • Travel & lodging$9,4288%
  • Food & beverage$10,9439%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$119,424 in reported general payments places this provider in the 95th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$5,114
Medicare patients
40
Services billed
10,299

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XyostedTestosterone Enanthate131$82,129
Testosterone179$28,618
Testosterone Cypionate330$16,434
Cabergoline43$3,058
Tamsulosin Hcl93$1,879
Finasteride38$641
Tadalafil22$614
Solifenacin Succinate16$360
Doxazosin Mesylate12$309
Anastrozole54$306
Dutasteride11$267
Alfuzosin Hcl ErAlfuzosin Hcl14$140

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Antares Pharma, Inc.Xyosted$76,892$82,129131 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Arlington

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →